DuPont de Nemours (NYSE:DD) reported Q2 2025 earnings on August 5, achieving adjusted EPS of $1.12, exceeding expectations, and GAAP revenue of $3,257 million, slightly above consensus. The company experienced significant growth in its electronics and healthcare segments, prompting management to raise full-year guidance despite a GAAP goodwill impairment in its Aramids business.